← Open Payments lookup

KATHRYN BREIHAN: Open Payments

NPI 1376917286 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,183 in 52 payments from 12 companies in 2025. Trend: 2023 $471 · 2024 $881 · 2025 $1,183

Food & beverage: $1,183
CompanyPaymentsAmount
Novo Nordisk Inc22$411
Lilly USA, LLC8$266
ABBVIE INC.6$205
Dexcom, Inc.4$86
AstraZeneca Pharmaceuticals LP3$49
PFIZER INC.2$32
Boehringer Ingelheim Pharmaceuticals, Inc.1$30
TMS NeuroHealth Centers Inc.2$27
Takeda Pharmaceuticals U.S.A., Inc.1$23
Amgen Inc.1$20

Products named: Ozempic, MAVYRET, ZEPBOUND, Dexcom G6 Transmitter, QULIPTA, MOUNJARO, Rybelsus, AIRSUPRA.

Industry payments across TX — which companies pay providers there.